블로그
- Tirzepatide sodium salt [B1370-449939][CAS no. 2933217-72-0]_BOC Sciences - 코아사이언스 Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor (GLP-1R) agonist.
- 한미약품 에페글레나타이드의 체중감소 효과 에페글레나타이드란 무엇인가 에페글레나타이드(efpeglenatide, 개발명 HM11260C)는 한미약품이 개발한 장기지속형 glucagon-like peptide-1 receptor
- Salcaprozate sodium [463293][CAS no. 203787-91-1 (sodium)]_MedKoo Biosciences - 코아사이언스 clinical studies, SNAC increases the oral bioavailability of peptides and proteins such as insulin and glucagon-like peptide-1 (GLP-1) receptor agonists by promoting transient, non-damaging transcellular permeation across
- Tirzepatide acetate [B1370-447164][CAS no. 2931515-08-9]_BOC Sciences - 코아사이언스 .# B1370-447164 / Size: 100mg Tirzepatide acetate is a dual GIP and GLP-1 receptor agonist used as a CAS NO.: 2931515-08-9 Category: Inhibitor Tag/Targets: GIP Receptor Glucagon-Like Peptide 1 (GLP-1) Molecular
- 크릴 오일이 단식이나 위고비, 마운자로와 같은 GLP-1 주사로 인한 체중 감량시의 부작용인 근육 손실(오젬픽 페이스)을 억제할 수 있다는 연구 Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight
-
크릴 오일이 단식이나 위고비, 마운자로와 같은 GLP-1 주사로 인한 체중 감량시의 부작용인 근육 손실(오젬픽 페이스)을 억제할 수 있다는 연구
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight
- Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries... racial and ethnic disparities in the use of sodium–glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor antagonists (GLP-1RAs) among older adults with type 2 diabetes and cardiorenal conditions
